An initiative of Flandersbio

Listed companies

Listed companies

in english

The combined market cap of Belgian SME biotech companies gained top position in the European ranking. The fact that the number of qualifying companies is 2 to 3 times smaller than in other European countries confirms the intrinsic quality of the Belgian public biotech sector.

Galapagos

Galapagos seeks to develop a robust portfolio of clinical-stage breakthrough therapies that have the potential to revolutionize existing treatment paradigms. Our ambition is to become a leading global biotechnological company, focused on the development and commercialization of novel medicines that will improve people’s lives.

Galapagos on FlandersBio.be

 

Chart IPO Statistics Pipeline Contact

Click on the chart to follow the daily exchange rate.

View the NYSE Euronext chart

  • Listing date:   05/05/2005

View chart De Tijd

Product Indications and progress Partner
GLPG0634 Rheumatoid Arthritis
 
GLPG0187 Metastasis
 
GLPG0492 Cachexia
 
GLPG0778 GSK
 
GLPG0555 GSK
 
GLPGXX GSK
 
GLPGXX Rheumatoid Arthritis
 

Investor Relations:
Elizabeth Goodwin, Director Investor Relations
Email:
Phone: +31 622 91 62 40

Address details:
Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium
Website: http://www.glpg.com
Email:

Back to top

Print